A Study to Exploratively Evaluate the Safety, Tolerability and Pharmacokinetics of DA-5223 Compared With DA-5223-R in Healthy Adult Subjects

Phamacokinetics and Safety Profiles of DA-5210 10/500mg in Healthy Subjects at Fasting State

NCT05098262 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics and Safety Profiles After Administration of DA-5211 and Co-administration of DA-5211-R1 and DA-5211-R2 in Healthy Adult Volunteers

NCT05132049 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial of Comparing DA-5222 Single-administration and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects

NCT06993181 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Phamacokinetics and Safety Profiles of DA-5213 10mg in Healthy Subjects

NCT05106205 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Food Effect on the Pharmacokinetics of DA-5223 in Healthy Adult Subjects

NCT07007520 ·Status: WITHDRAWN ·Phase: PHASE1

A Clinical Trial to Compare the Safety, Tolerability, and PK Properties of DA-5216 and DA-5216-R and to Evaluate the Food Effect on DA-5216.

NCT05506007 ·Status: UNKNOWN ·Phase: PHASE1

Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fed State

NCT07342062 ·Status: COMPLETED ·Phase: PHASE1

Phamacokinetics and Safety Profiles of DA-5210 10/1000mg in Healthy Subjects at Fasting State

NCT05108571 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial Comparing Single-administration of DA-5222 and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects in Fed State

NCT07046715 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics and Safety Profiles After Administration of DA-5218 and Co-administration of DA-5218-R1, DA-5218-R2 and DA-5218-R3 in Healthy Adult Volunteers

NCT05449704 ·Status: UNKNOWN ·Phase: PHASE1

Phamacokinetics and Safety Profiles of DA-1229_01 5/1000mg in Healthy Subjects at Fed State

NCT05739916 ·Status: UNKNOWN ·Phase: PHASE1

Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects (DA-2811)

NCT04938752 ·Status: COMPLETED ·Phase: PHASE1

To Evaluate Effect of Food of DA-5222 in Healthy Adult Subjects

NCT06993168 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Phamacokinetics and Safety Profiles of DA-1229_01 5/1000mg in Healthy Subjects at Fasting State

NCT05739903 ·Status: UNKNOWN ·Phase: PHASE1

Pharmacokinetics and Safety Profiles of DA-1229_01 in Healthy Subjects at Fasting State

NCT07297940 ·Status: COMPLETED ·Phase: PHASE1

Bioequivalence Study for the Safety and the Pharmacokinetics of DWC202313, DWC202314, and DWJ1622 in Healthy Volunteers Under Fed Condition.

NCT07267221 ·Status: RECRUITING ·Phase: PHASE1

Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fasting State

NCT05739851 ·Status: UNKNOWN ·Phase: PHASE1

Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fed State

NCT05739877 ·Status: UNKNOWN ·Phase: PHASE1

Pharmacokinetics and Safety Study of DWJ1392 and DWC20164 in Healthy Male Volunteers

NCT03016520 ·Status: UNKNOWN ·Phase: PHASE1

A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers

NCT05192395 ·Status: COMPLETED ·Phase: PHASE1

Phase I Clinical Study to Investigate the Pharmacokinetics and Safety/Tolerability of DA-7218 in Healthy Male Volunteers

NCT02097043 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics of DWP16001 Drug A and C

NCT05465668 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial to Evaluate the Pharmacokinetic Characteristics of DW5221 and DW5221-R

NCT06147908 ·Status: COMPLETED ·Phase: PHASE1

To Evaluate the Safety and the Pharmacokinetics of NVP-2203

NCT05725252 ·Status: COMPLETED ·Phase: PHASE1

Phase 1 Study of DHP2302R1 and DHP2302R2 in Healthy Adult Volunteers

NCT06318845 ·Status: COMPLETED ·Phase: PHASE1